Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
New Hampshire Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Centogene NV
CENTOGENE Receives Delisting Notice From Nasdaq
August 07, 2024
From
Centogene NV
Via
GlobeNewswire
Tickers
CNTG
CENTOGENE Publication in Brain Journal Reveals 15% of Parkinson’s Disease Cases Are Linked to Genetic Factors
August 01, 2024
From
Centogene NV
Via
GlobeNewswire
Tickers
CNTG
C-Path and CENTOGENE MOU to Enhance Collaboration in Lysosomal Disease Research and Drug Development
June 20, 2024
From
Centogene NV
Via
GlobeNewswire
Tickers
CNTG
CENTOGENE Announces Adoption of All Resolutions Tabled at 2024 Annual General Meeting
May 31, 2024
From
Centogene NV
Via
GlobeNewswire
Tickers
CNTG
CENTOGENE Reports Full Year 2023 Financial Results and Recent Business Highlights
May 15, 2024
From
Centogene NV
Via
GlobeNewswire
Tickers
CNTG
CENTOGENE Secures Approx. $20 Million to Strengthen Cash Position
May 15, 2024
From
Centogene NV
Via
GlobeNewswire
Tickers
CNTG
CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease
May 14, 2024
From
Centogene NV
Via
GlobeNewswire
Tickers
CNTG
EVO
CENTOGENE Biodatabank Grows to Incorporate Disease Insights From Over 850,000 Diverse Patients
May 10, 2024
From
Centogene NV
Via
GlobeNewswire
Tickers
CNTG
CENTOGENE Receives Nasdaq Non-Compliance Notice
April 02, 2024
From
Centogene NV
Via
GlobeNewswire
Tickers
CNTG
CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders
March 19, 2024
From
Centogene NV
Via
GlobeNewswire
Tickers
CNTG
TAK
CENTOGENE Collaborates on Research Published in Science Showing Immunopathological Landscape of Human Pre-TCRα Deficiency
February 29, 2024
From
Centogene NV
Via
GlobeNewswire
Tickers
CNTG
CENTOGENE Announces Receipt of Nasdaq Notice of Delisting and Intention to Request a Hearing
February 28, 2024
From
Centogene NV
Via
GlobeNewswire
Tickers
CNTG
CENTOGENE Explores Strategic Alternatives
February 28, 2024
From
Centogene NV
Via
GlobeNewswire
Tickers
CNTG
CENTOGENE and the Laboratory of Human Genetics of Infectious Diseases at Institut Imagine Announce Rare Disease Research Collaboration
January 25, 2024
From
Centogene NV
Via
GlobeNewswire
Tickers
CNTG
CENTOGENE Receives French Research Tax Credit Accreditation
January 24, 2024
From
Centogene NV
Via
GlobeNewswire
Tickers
CNTG
CENTOGENE and The Michael J. Fox Foundation Announce Research Project to Validate Genetic Risk Factors of Parkinson’s Disease Using Multiomics
January 23, 2024
From
Centogene NV
Via
GlobeNewswire
Tickers
CNTG
CENTOGENE Announces Preliminary Full Year 2023 Revenue
January 18, 2024
From
Centogene NV
Via
GlobeNewswire
Tickers
CNTG
CENTOGENE Announces Voting Results of Extraordinary General Meeting
December 19, 2023
From
Centogene NV
Via
GlobeNewswire
Tickers
CNTG
CENTOGENE’s Frontotemporal Dementia (FTD) Genetic Study, EFRONT, Reaches Initial Patient Enrollment Milestone
December 13, 2023
From
Centogene NV
Via
GlobeNewswire
Tickers
CNTG
CENTOGENE and Lifera, a Public Investment Fund (PIF) Company, Complete Strategic Joint Venture Transaction
November 28, 2023
From
Centogene NV
Via
GlobeNewswire
Tickers
CNTG
CENTOGENE, University College London, and Global Team of Researchers Discover Gene Associated With New Neurodevelopmental Disease Linked to Early-Onset Dystonia and Parkinsonism
November 14, 2023
From
Centogene NV
Via
GlobeNewswire
Tickers
CNTG
CENTOGENE Expands Multiomic Diagnostic Portfolio With Newly-Launched Transcriptomic Offering
October 10, 2023
From
Centogene NV
Via
GlobeNewswire
Tickers
CNTG
CENTOGENE to Present at H.C. Wainwright 25th Annual Global Investment Conference
September 11, 2023
From
Centogene NV
Via
GlobeNewswire
Tickers
CNTG
CENTOGENE Reports First Half 2023 Financial Results
September 07, 2023
From
Centogene NV
Via
GlobeNewswire
Tickers
CNTG
CENTOGENE Announces Publication Establishing Lyso-Gb1 as a Predictive Biomarker for Gaucher Disease Patients
September 01, 2023
From
Centogene NV
Via
GlobeNewswire
Tickers
CNTG
CENTOGENE Receives Nasdaq Non-Compliance Notification Regarding Minimum Market Value of Publicly Held Shares Deficiency
August 31, 2023
From
Centogene NV
Via
GlobeNewswire
Tickers
CNTG
CENTOGENE to Participate in Upcoming Conferences in August
August 07, 2023
From
Centogene NV
Via
GlobeNewswire
Tickers
CNTG
CENTOGENE Regains Compliance With Nasdaq Listing Requirements
July 14, 2023
From
Centogene NV
Via
GlobeNewswire
Tickers
CNTG
CENTOGENE Biodatabank Reveals Unique Genetic Variants in World's Largest Niemann-Pick Type C1 Disease Cohort
July 12, 2023
From
Centogene NV
Via
GlobeNewswire
Tickers
CNTG
CENTOGENE Announces Approval of All Resolutions Tabled at 2023 Annual General Meeting
June 30, 2023
From
Centogene NV
Via
GlobeNewswire
Tickers
CNTG
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.